Sahar Bedrood, MD, discusses her experience with the LEOS endoscopic laser system's enhanced precision and efficiency, promising improved patient outcomes in glaucoma surgery.
News
The novel therapeutic for keratoconus does not require corneal epithelium removal and is slated to launch commercially in early 2026.
A new study reveals a promising drug reduces vision loss in Stargardt disease, showing significant safety and efficacy over 2 years.
A study shows enhanced safety and efficacy in epi-on cross-linking for keratoconus, utilizing oxygen-rich boost goggles during treatment.
At the 2025 Academy of American Ophthalmology meeting, Prof Stalmans described safety and efficacy benefits of disposable non-contact vitrectomy lenses
The investigators noted that this report is the first about subretinal drusenoid deposits in Black and Hispanic patients with age-related macular degeneration
The video-driven platform will improve workflow, education and engagement, said Inder Paul Singh, MD
The full range of vision lens debuted at the 2025 ESCRS meeting in Copenhagen
Patients with proliferative diabetic retinopathy, central retinal vein occlusion and branch retinal vein occlusion experienced fluctuating retinal perfusion, investigators reported
The agenda includes subspecialty days, evening events and partner programmes from practice management organisations
Research finding challenge the widely-held notion that cosmetic contact lenses are the safest technique for changing eye colour
A pair of studies, conducted in Taiwan and China, indicate that red light therapy could serve as an effective and safe alternative to atropine
Biomarkers and fine-tuned staging are key to progress in improving retinal care, according to Fanka Gilevska, MD, PhD
Patient response focused on perceived vision-related quality of life outcomes, investigators said
The procurement follows an 18-month pilot at a high-volume surgery in Dundee, Scotland
EyeArt uses artificial intelligence for autonomous detection of vision-threatening diabetic retinopathy
The newly-approved technology delivers low-dose microcurrents through closed eyelids to stimulate retinal cells
The current staging system fails to fully capture the neurovascular unit's status, said Stela Vujosevic, Md, PhD, FEBO
Alteogen received a positive CHMP opinion for EYLUXVI in July 2025
Leading companies spotlight innovations in cataract and refractive surgery at the 43rd ESCRS Congress in Copenhagen
At the ESCRS meeting, cataract surgeons can get familiar with BVI's Virtuoso platform and VirtuaLens' immersive VR IOL simulator
Alcon, Bausch + Lomb and Johnson & Johnson will debut new research findings during the European Society of Cataract and Refractive Surgeons Congress in Copenhagen, Denmark
Ahead of the ESCRS congress and iNovation day, we go behind the scenes with Ciliatech founder Philippe Sourdille, MD, and president Olivier Benoit
Dr Ramtohul's research uses electrophysiologic testing to study the retinal ganglion cells
The US Food and Drug Administration (FDA) also granted RMAT designation for MCO-010 in Stargardt disease (SD).
Presentation topics will include therapies for age-related macular degeneration, X-linked retinitis pigmentosa and other retinal pathologies
Clinical leaders including Susan Schneider, MD; Lejla Vajzovic, MD; and Harvey Uy, MD, will share new clinical findings
An understanding of GA growth kinetics is key to addressing the pathophysiology of age-related macular degeneration
Advertisement
Advertisement
